why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: June 18, 2025

Clinical Trial: Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Diabetic Kidney Disease

Study Type: INTERVENTIONAL


Official Title: Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

Brief Summary: Diabetes had global prevalence of 9% in 2014 and is increasing alarmingly, affecting approximately 387 million people worldwide.It is strongly linked to complications, like chronic kidney failure, blindness and neurdegeneration.From 1999-2006, prevalence of chronic kidney disease (CKD) stage 1-2 was 11.5%, and stage 3-4 was 58%, while its prevalence in Pakistan is 12.5%.CKD is a pathophysiological process with multiple etiologies, eventually resulting in irreversible nephron damage and leading to End Stage Renal…

Read more